Rhythmic behaviors are a fundamental feature of all organisms. Pharyngeal pumping, the defecation cycle, and gonadal-sheath-cell contractions are three well-characterized rhythmic behaviors in the nematode C. elegans. The periodicities of the rhythms range from subsecond (pharynx) to seconds (gonadal sheath) to minutes (defecation). However, the molecular mechanisms underlying these rhythmic behaviors are not well understood. Here, we show that the C. elegans Rho/Rac-family guanine nucleotide exchange factor, VAV-1, which is homologous to the mammalian Vav proto-oncogene, has a crucial role in all three behaviors. vav-1 mutants die as larvae because VAV-1 function is required in the pharynx for synchronous contraction of the musculature. In addition, ovulation and the defecation cycle are abnormal and arrhythmic. We show that Rho/Rac-family GTPases and the signaling molecule inositol triphosphate (IP 3 ) act downstream of VAV-1 signaling and that the VAV-1 pathway modulates rhythmic behaviors by dynamically regulating the concentration of intracellular Ca 2+ .
Introduction
Rhythmic activities are ubiquitous biological phenomena and can be observed in cells, tissues, and the behavior of most organisms. Biological rhythms regulate many diverse processes, such as heartbeat, breathing, locomotion, and gut peristalsis. The molecular machinery underlying the generation and regulation of rhythms less than a day in duration-known as ultradian rhythms-are not well understood. To gain a molecularly based understanding of these biological rhythms, the use of a genetically tractable organism has certain advantages. C. elegans hermaphrodites have three well-characterized rhythmic behaviors. These include pharyngeal peristalsis that occurs every 1-2 s (Avery and Thomas, 1997 Here we have found that VAV-1, the sole Vav-family protein in C. elegans, has a critical role in the three major rhythmic behaviors observed in the nematode. VAV-1 is expressed in the relevant tissues, and deletion of the vav-1 gene results in a disruption of pharyngeal pumping and consequent early larval lethality. Lethality and pumping are rescued in transgenic vav-1 deletion mutants by pharynx-specific expression of VAV-1. However, the transgenic vav-1 mutants display severe defects in fertility and defecation secondary to disrupted gonadal and intestinal contractile rhythms, respectively. Our results provide new insights into the function of Vav proteins and demonstrate that VAV-1 has critical roles in regulating Ca 2+ signaling and the generation of rhythmic behaviors.
Results

vav-1 Encodes a Putative Guanine Nucleotide Exchange Factor
The C. elegans genome contains a single putative open reading frame that encodes a polypeptide with greatest identity to members of the Vav family of GEFs. We isolated a full-length cDNA that is predicted to encode a 1007 amino acid protein, VAV-1 ( Figure 1A ). VAV-1 has . The corresponding tyrosine residues are conserved in C. elegans VAV-1 (Tyr183, Tyr200, and Tyr217) ( Figure  1A ), suggesting that VAV-1 might be regulated by a similar mechanism.
To investigate the function of these conserved tyrosines, we used site-directed mutagenesis to generate Y217F and Y183F/Y200F/Y217F (Y3XF) mutant variants of VAV-1. We expressed these VAV-1 variants in transgenic worms using the body-wall-muscle-specific promoter, myo-3. We found that expression of the single Y217F and the triple Y3XF mutant construct in the body-wall muscle led to a dominant hypercontracted and uncoordinated phenotype ( Figures 1E and 1F) . Additionally, we generated an N-terminal deletion of vav-1, known to result in oncogenic activity of mammalian Vav proteins (Bustelo, 2001; Turner and Billadeau, 2002), in which the CH and AD domains were removed. Expression of this deletion construct, vav-1(N⌬), in the body-wall muscle using the myo-3 promoter caused a phenotype identical to that observed in the Y217F and the Y3XF mutants ( Figure 1G ). To test whether this phenotype was due to unregulated GEF activity, we modified the vav-1(N⌬) construct by introducing the L260Q mutation (vav-1(N⌬);L260Q). The corresponding mutation in vertebrate Vav1 (L213Q) has been shown to substantially reduce in vivo GEF activity (Crespo et al., 1996 (Crespo et al., , 1997 . As predicted, transgenic worms that expressed vav-1(N⌬);L260Q had a wild-type phenotype, indicating that the dominant phenotype observed in transgenic worms that expressed vav-1(N⌬) was due to GEF activity ( Figure 1H ). We also used a biochemical assay to directly determine whether VAV-1 has GEF activity. We found that the purified DH/PH domain of VAV-1 was sufficient to promote GDP/GTP exchange on C. elegans Rho/Rac GTPases ( Figure S1 ). These data demonstrate that C. elegans VAV-1 has GEF activity and that this activity, like that of the mammalian Vav family members, is regulated by tyrosine phosphorylation.
vav-1 Is Expressed in Tissues that Rhythmically Contract
To determine which cells express VAV-1, we used vav-1 regulatory sequences to drive the expression of full length VAV-1 fused to the reporter molecule green fluorescent protein (GFP). In transgenic animals that express VAV-1::GFP, we observed strong GFP fluorescence in the pharynx, proximal gonad, spermatheca, intestine, and rectal epithelia (Figures 1I-1K ). In the pharynx, VAV-1::GFP was observed in most cell types, including muscle cells, marginal cells, epithelial cells, neurons, and gland cells ( Figure 1I ). In the gonad, VAV-1::GFP was observed in the contractile sheath cells adjacent to the spermatheca ( Figure 1J ). The expression of VAV-1::GFP in the intestine was limited to the four most posterior cells (int8 and int9) and the three rectal epithelial cells ( Figure 1K ). Additionally, VAV-1::GFP expression was observed in the distal gonad, body-wall muscle, and vulval epithelia (data not shown).
vav-1 Mutants Cannot Feed and Die Early in Development
To determine the function of VAV-1, we generated a deletion mutation that removed approximately 2 kb of genomic sequence ( Figure S2 ). Homozygous vav-1(ak41) mutants survive for many days but arrest at the first (L1) larval stage. Pharyngeal pumping in vav-1 mutants was grossly abnormal-pharyngeal muscle contractions were either absent for long periods or asynchronous. We did not observe any obvious defects in pharyngeal morphology that might explain the disrupted pumping behavior. Likewise, the pharyngeal muscle displayed a normal radial arrangement of actin, and we observed no visible defects at the light-microscopic level in the organization of pharyngeal adherens junctions ( Figure S3 ). Analysis of two other deletion alleles, vav-1(ok425) and vav-1(tm402), revealed an L1 lethal phenotype identical to vav-1(ak41) mutants.
Pharyngeal function and lethality were rescued by expressing a VAV-1::GFP fusion protein under control of vav-1 regulatory sequences (see below and Experimental Procedures). To test whether disruption of GEF activity accounted for the mutant phenotypes, we modified the rescuing VAV-1::GFP construct by introducing the L260Q mutation (Crespo et al., 1996 (Crespo et al., , 1997 . Transgenic vav-1 mutants that expressed VAV-1(L260Q)::GFP at levels similar to rescuing VAV-1::GFP were defective in pharyngeal pumping, died as L1 larvae, and could not be distinguished from vav-1 mutants ( Figure S4 ). These results indicate that GEF activity is required for the normal function of vav-1.
vav-1 Is Required for Coordinated Pharyngeal Contraction
Analysis of the pharyngeal defect in vav-1(ak41) mutants using video microscopy and electrical recordings revealed asynchronous electrical activity of the pharyngeal musculature. During normal feeding, the radial muscles of the pharynx contract simultaneously to suck food into the opened lumen. A short while later, this process is reversed and the muscles relax, expelling fluid while retaining food (Albertson and Thomson, 1976) . For this process to work efficiently, the musclecell contractions and relaxations must be synchronized (Avery and Thomas, 1997 Thomas, 1997) . Each pump is associated with an excitatory depolarizing wave (E) followed by a plateau phase (P), often punctuated by brief negative spikes, and ending with an inhibitory hyperpolarizing wave (R) (Figure 2A 2+ imaging data suggest a specific requirement for VAV-1 in pharyngeal muscle, we attempted to rescue the vav-1 mutant phenotype in transgenic animals by restricting VAV-1 expression to pharyngeal muscle using the myo-2 promoter (Okkema et al., 1993) . vav-1 mutants that express Pmyo-2::VAV-1 have restored pharyngeal pumping, indicating that the pumping defects were due to altered pharyngeal muscle function ( Figure 2J ).
vav-1 Modulates Ovulation Rate via IP 3 and the Rho GTPases
We were able to characterize the function of VAV-1 in tissues other than the pharynx by studying transgenic vav-1 mutants that expressed the Ppha-4::VAV-1 or Pmyo-2::VAV-1 transgene. Although these animals survived to adulthood and appeared to have normal locomotion, they had reduced fertility. The average brood size of transgenic hermaphrodites (vav-1(ak41);Ppha-4::VAV-1) was 44 ± 7.7 (n = 20), whereas wild-type hermaphrodites had 284 ± 4.9 progeny (n = 20) ( Figure 3A) . Furthermore, we found that vav-1(ak41);Pmyo-2::VAV-1 transgenic mutants had 21 ± 4.1 progeny (n = 40).
Vertebrate Vav1 is required for TCR-dependent intracellular Ca 2+ To investigate whether vav-1 acts in an IP 3 signaling pathway, we generated double mutants or used RNA interference (RNAi) to knock down gene function. The brood size of itr-1(gf);vav-1(ak41);Pmyo-2::VAV-1 and itr-1(gf);vav-1(ak41);Ppha-4::VAV-1 double mutants was significantly larger than vav-1(ak41);Pmyo-2::VAV-1 and vav-1(ak41);Ppha-4::VAV-1 mutants alone, respectively ( Figure 3A) . Additionally, lfe-2(RNAi) or ipp-5(RNAi) to vav-1(ak41);Pmyo-2::VAV-1 mutants significantly suppressed the brood defect ( Figure 3A) . Further support for the hypothesis that vav-1 functions to regulate IP 3 comes from double mutants containing a reduction-offunction mutation in the IP 3 receptor, itr-1(rf), and vav-1(ak41);Ppha-4::vav-1 mutants. These mutants were almost completely sterile, displaying phenotypic enhancement over either single mutation ( Figure 3A) . To investigate the possibility of vav-1 acting in the EGF signaling pathway during ovulation, we made double mutants with vav-1;Ppha-4::VAV-1 and a gain-of-function mutation in the EGF receptor, let-23(gf). Unlike itr-1(gf), let-23(gf) did not significantly improve the brood-size defect observed in vav-1(ak41);Ppha-4:: VAV-1 mutants ( Figure 3A ). This suggests that the let-23/EGFR acts upstream of vav-1 to promote ovulation.
Since vav-1 is also expressed in the vulval epithelia, it is possible that an egg-laying defect may contribute to the smaller brood size observed in vav-1(ak41);Ppha-4::VAV-1 mutants. However, mutants that are defective in egg laying typically are bloated with retained eggs. In contrast, vav-1 mutants did not appear bloated by visual inspection. Eggs that are retained due to a laying defect will have progressed further in development. Therefore, a microscopic examination of recently laid eggs provides a more sensitive assay for defects in egg laying. Eggs from wild-type and vav-1(ak41);Ppha-4:: VAV-1 mutants were indistinguishable, indicating that vav-1 mutants do not have an egg-laying defect ( Figure  3B Low brood size can be caused by other factors, such as impaired sperm production or mobility or defective ovulation. VAV-1 is expressed in the gonadal-sheath cells and spermatheca, suggesting that VAV-1 may also be required for ovulation or sperm function. However, mating wild-type males with vav-1 mutant hermaphrodites did not restore the brood size to normal levels ( Figure 3C ), indicating that the reduced fertility of vav-1 mutants was more likely due to an ovulation defect. To test this hypothesis, we video-recorded sheathcell contractions and ovulations from immobilized worms. We found that the basal sheath-cell contraction rate was slower in mutants. In wild-type animals, the average basal contraction rate is approximately 8 contractions/min, whereas in vav-1;Ppha-4::VAV-1 and vav-1;Pmyo-2::VAV-1 mutants the contraction rate is approximately 5 and 2 contractions/min, respectively ( Figure 3D) .
We next examined the cellular events associated with ovulation. In wild-type animals, oocytes align on the proximal-distal axis of the gonad and undergo a series of changes during ovulation that occur in an assembly-line manner (McCarter et al., 1999) . These consist of oocyte maturation, which includes nuclear-envelope breakdown and cortical rearrangement; dilation of the spermatheca; and sheath-cell contractions, which pull the dilated spermatheca over the mature oocyte, allowing entry into the spermatheca and fertilization ( Figure 4A) . In both vav-1(ak41);Ppha-4::VAV-1 and vav-1(ak41);Pmyo-2::VAV-1 mutants, the oocytes developed normally until they reached the spermatheca. However, at this point, several defects were observed, such as ovulation of immature oocytes (Figure 4B ), premature spermatheca constriction (Figure 4C) , and overexten- sion of the spermatheca past the proximal oocyte. (Figure 4D) . These defects were associated with constriction and damage of the oocyte. Additionally, we occasionally observed that the oocytes did not enter the spermatheca in vav-1(ak41);Pmyo-2::VAV-1 mutants and arrested with an endomitotic phenotype ( Figure 4E ). In sum, our data indicate that vav-1 is required for the normal coordination of sheath-cell contractions, spermathecal dilation, and oocyte maturation and likely acts through the IP 3 R.
Since we found that VAV-1 acts as a Rho/Rac-family guanine nucleotide exchange factor ( Figure S1 ), we investigated whether disrupting any of the Rho/Rac GTPases of C. elegans causes defects in ovulation. C. elegans contains three genes encoding Rac GTPases, ced-10, mig-2, and rac-2 (Chen et al., 1993a; Lundquist et al., 2001) ; one Rho GTPase, rho-1; and one Cdc42 GTPase, cdc-42 (Chen et al., 1993b; Chen and Lim, 1994). Analysis of RNAi knockdown of candidate Rho/Rac GTPaseencoding genes or analysis of known mutants revealed that only rho-1(RNAi) had a phenotype similar to vav-1(ak41);Pmyo-2::VAV-1 mutants ( Figure 4F) . Doublemutant analysis of cdc-42(RNAi);mig-2 and cdc-42(RNAi);ced-10 revealed severe migration defects of the gonadal distal-tip cells, resulting in abnormal gonad development. ced-10;mig-2 mutants also had gonadal migration defects as well as oocyte development defects. These findings prevented analysis of ovulation in these double mutants. These data indicate that vav-1 is involved in regulating ovulation by modulating IP 3 signaling and that this signaling pathway may involve the small GTPase rho-1.
vav-1 Function Is Required for a Normal Defecation Cycle
Defecation in C. elegans is composed of three sequential motor steps: posterior body-wall-muscle contraction (pBoc), anterior body-wall-muscle contraction (aBoc), and enteric-muscle contraction (Emc) leading to expulsion (Avery and Thomas, 1997) . This motor program is repeated approximately every 45-50 s. In vav-1;Ppha-4::VAV-1 mutants, the three sequential motor steps occurred normally, i.e., once initiated, the timing and order of the three steps was normal. However, the cycle period (defined by the interval between successive pBocs) was irregular, and the mean cycle time was lengthened to approximately 85 s (Figures 5A and 5C ). Because the pha-4 promoter is weakly expressed in intestinal cells (Kalb et al., 1998), we also examined defecation in vav-1(ak41);Pmyo-2::VAV-1 mutants. While these animals still defecate, the average cycle duration was approximately 195 s, the cycle was highly variable and irregular (Figures 5A-5C) , and frequently the expulsion step was skipped.
We used mosaic analysis to identify the cells in which VAV-1 function is required for the periodicity of defecation (Figure 6 ). To do this, we characterized defecation in transgenic vav-1 mutants expressing two linked transgenes: the vav-1 rescuing genomic clone and a Psur-5::NLS::GFP clone that is expressed in the nuclei of all somatic cells and is a well-established tool for mosaic analysis (Yochem et al., 1998) . We found that, in all cases, young adult mosaic animals lacking the transgenes in the E lineage, which gives rise to the intestine, were defecation defective (Figure 6 ). Furthermore, in cases where the transgenes were present in the E lineage, the defecation cycle was normal.
vav-1 Controls the Duration of the Defecation Cycle via IP 3 and the Rho/Rac GTPases
The IP 3 receptor has also been implicated in the control of the defecation cycle. Loss-of-function mutations in itr-1 result in the slowing or absence of the pBoc-pBoc defecation cycle (Dal Santo et al., 1999). To investigate whether the gain-of-function itr-1(gf) mutation could suppress the impaired defecation in vav-1 mutants, we examined the defecation cycle in itr-1(gf);vav-1(ak41); Pmyo-2::VAV-1 mutants. Consistently, the defecationcycle rhythm was improved in itr-1(gf);vav-1(ak41); Pmyo-2::VAV-1 double mutants compared to vav-1(ak41);Pmyo-2::VAV-1 single mutants. (Figure 5A ). We also found partial suppression of the defecation-cyclerhythm defect in vav-1(ak41);Pmyo-2::VAV-1 mutants treated with lfe-2(RNAi) (Figure 5A ). In contrast, we did not observe suppression in mutants treated with ipp-5(RNAi) (Figure 5A ). Additionally, we examined double mutants containing a reduction-of-function allele of itr-1 and vav-1(ak41);Ppha-4::VAV-1 and found that the defecation cycle was significantly extended in the double mutant as compared to the single mutants (Figure 5A) . These data suggest that vav-1 functions via IP 3 signaling to regulate the defecation cycle. Does VAV-1 signal through the C. elegans Rho/Rac GTPases to control the timing of the defecation cycle? To determine whether these genes are involved, we examined the defecation cycle in known mutants or used RNAi knockdown of specific Rho/Rac GTPases. RNAi knockdown of cdc-42, ced-10, mig-2, rac-2, and rho-1 individually did not reveal any significant defects in defecation timing ( Figure 5A and data not shown) . Additionally, analysis of ced-10 and mig-2 single mutants did not reveal any significant defecation timing defects ( Figure 5A ). Given that there are five genes encoding Rho/Rac GTPases in C. elegans, it is possible that there is genetic redundancy. Consistent with this, we found that RNAi knockdown of rho-1 in the mutant background of ced-10 or mig-2 caused an extended and arrhythmic defecation cycle (Figures 5A and 5C) . Moreover, we found that ced-10;mig-2 double mutants had significantly lengthened and arrhythmic defecation cycles (Figures 5A and 5C ). We could not extend this analysis because rho-1 RNAi knockdown in the ced-10;mig-2 double mutant was larval lethal. In contrast, we observed no defecation defects in cdc-42(RNAi); mig-2 and cdc-42(RNAi);ced-10 mutants. These data demonstrate that ced-10, mig-2, and rho-1 have a redundant function in controlling the periodicity of the defecation cycle.
To further dissect the role of vav-1 and the Rho/Rac GTPases, we engineered a constitutively active GEF mutation (Y3XF) (see above) in VAV-1 that was expressed solely in the intestine by the ges-1 promoter, Pges-1::vav-1(gf). Expression of Pges-1::vav-1(gf) in wild-type animals resulted in abnormal defecation- cycle timing. The defecation cycle of these animals was arrhythmic and extended compared to wild-type animals that did not express the Pges-1::vav-1(gf) transgene ( Figure 5A ). To determine whether the Rho/Rac GTPases act downstream of vav-1, we carried out RNAi knockdown experiments of the Rho/Rac GTPases in animals expressing the Pges-1::vav-1(gf) transgene. We found that RNAi knockdown of ced-10, mig-2, and rho-1 could suppress the defecation timing defect observed in Pges-1::vav-1(gf)-expressing animals ( Figure  5A ). In contrast, cdc-42(RNAi) did not significantly suppress the defecation timing defects of Pges-1::vav-1(gf)-expressing animals ( Figure 5A ). These data indicate that ced-10, mig-2, and rho-1 act downstream of vav-1 to regulate defecation-cycle timing.
VAV-1 may function in a signaling pathway to activate phosphatidylinositol 4-phosphate 5 kinase (PIP5K) to generate phosphatidylinositol(4,5)biphosphate (PIP2), the substrate for IP 3 production. To test this hypothesis, we knocked down the function of ppk-1/PIP5K by RNAi and found an almost complete absence of the defecation cycle (no pBoc observed in > 600 s of observation), indicating a critical role for PIP5K in the control of defecation. To test whether VAV-1 functions upstream of PIP5K, we also knocked-down ppk-1/PIP5K in transgenic worms that expressed vav-1(gf). The phenotype of the worms following RNAi was similar to ppk-1 alone (no pBoc observed in > 600 s of observation), indicating that ppk-1/PIP5K acts downstream of vav-1. These results indicate that IP 3 production is dependent on the activation of VAV-1
Intracellular Ca
2+ Oscillations Are Abnormal in vav-1 Mutants Our genetic evidence indicates that vav-1 is required for IP 3 generation. Thus, in vav-1 mutants, the release of Ca 2+ from intracellular stores may be impaired, leading to impaired rhythmic contractility. Since Ca 2+ signaling in the pharynx was abnormal in vav-1 mutants, we also investigated Ca 2+ signaling in the intestines. To analyze intracellular Ca 2+ oscillations, we loaded isolated intestines with the indicator Fluo-4 and imaged fluorescence intensity (see Experimental Procedures). In wild-type animals, Ca 2+ oscillations were observed at very regular intervals, similar to the timing of the defecation cycle, and were highly reproducible ( Figures  7A, 7D, and 7E) . In contrast, vav-1;Pmyo-2::VAV-1 mutants had an arrhythmic and lengthened Ca 2+ oscillation frequency similar to the defective defecation behavior observed in these animals ( Figures 7B, 7D, and 7E) . Additionally, we found that the lengthened Ca 2+ oscillation frequency observed in vav-1;Pmyo-2::VAV-1 mutants was suppressed by a gain-of-function mutation in itr-1; however, the frequency of Ca 2+ signaling remains arrhythmic (Figures 7D and 7E) . Consistent with the Rho/Rac GTPases acting downstream of VAV-1, ced-10;mig-2 mutants showed a phenotype similar to vav-1; Pmyo-2::VAV-1. The double mutant had arrhythmic and lengthened defecation cycles (Figures 7C-7E) . These results suggest that VAV-1 regulates Ca 2+ oscillations via Rho GTPases within the intestines to control the rhythmic behavior of the defecation cycle.
Discussion
We have found that vav-1 is required for three different rhythmic behaviors: the synchronous pumping of the pharynx, the coordinated contractions of sheath cells and dilation of the spermatheca, and the periodicity of the defecation cycle. We have also shown that, in the intestines, VAV-1 function is dependent on members of the Rho/Rac family of GTPases and IP 3 signaling. These data suggest that VAV-1 is part of a signaling pathway used by a variety of tissues to control the release of intracellular Ca 2+ and generate rhythmic activity. Consistent with this model, we observed abnormal Ca 2+ transients in pharyngeal muscle and the intestines of vav-1 mutants and Rho/Rac double mutants. In summary, our data indicate that VAV-1 has an evolutionarily conserved role in Ca 2+ signaling and modulates three major rhythmic behaviors found in C. elegans. These rhythms are considered nonneurogenic in that they do not appear to be directly driven by nervous-system input and thus may be more analogous to the intrinsic rhythms found in tissues such as the vertebrate heart, which are modulated by external signals. In the absence of VAV-1, Ca 2+ signaling and pumping, ovulation, and defecation behaviors are still present, but the cycles are longer and arrhythmic. Because VAV-1 is required for three different rhythmic behaviors in C. elegans, VAV-1 may act as a global regulator of biological rhythms through its modulation of Ca 
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